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6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB)
catalyzes the synthesis and degradation of fructose-2,6-
bisphosphate, a key modulator of glycolysis-gluconeogenesis.
To gain insight into the molecular mechanism behind hor-
monal and nutritional regulation of PFKFB expression, we
have cloned and characterized the proximal promoter region
of the liver isoform of PFKFB (PFKFB1) from gilthead sea
bream (Sparus aurata). Transient transfection of HepG2 cells
with deleted gene promoter constructs and electrophoretic
mobility shift assays allowed us to identify a sterol regulatory
element (SRE) to which SRE binding protein-1a (SREBP-1a)
binds and transactivates PFKFB1 gene transcription. Mutat-
ing the SRE box abolished SREBP-1a binding and transacti-
vation. The in vivo binding of SREBP-1a to the SRE box in the
S. aurata PFKFB1 promoter was confirmed by chromatin im-
munoprecipitation assays. There is a great deal of evidence
for a postprandial rise of PFKB1mRNA levels in fish and rats.
Consistently, starved-to-fed transition and treatment with
glucose or insulin increased SREBP-1 immunodetectable lev-
els, SREBP-1 association to PFKFB1 promoter, and PFKFB1
mRNA levels in the piscine liver. Our findings demonstrate
involvement of SREBP-1a in the transcriptional activation of
PFKFB1, andwe conclude that SREBP-1amay exert a key role
mediating postprandial activation of PFKFB1 transcription.
(Endocrinology 147: 3446–3456, 2006)
THE BIFUNCTIONAL ENZYME 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB, EC
2.7.1.105/EC 3.1.3.46) catalyzes the synthesis and degrada-
tion of fructose-2,6-bisphosphate (Fru-2,6-P2), a key modu-
lator of glycolysis-gluconeogenesis through allosteric acti-
vation of 6-phosphofructo-1-kinase and simultaneous
inhibition of fructose-1,6-bisphosphatase (1–3). PFKFB is a
homodimer. The N-terminal region of each monomer is
involved in the control of both kinase and bisphosphatase
enzyme activities of PFKFB. The sequence responsible for
kinase activity is located next to this region, whereas the
amino acids critical for bisphosphatase activity are located
in the C-terminal domain of the protein. Both activities of
PFKFB depend on the state of phosphorylation of the en-
zyme; phosphorylation inhibits kinase activity and activates
phosphatase activity (4–6). The elevated homology of fish
and mammalian PFKFB amino acid sequences and the pre-
dicted molecular models of fish PFKFB and rat isoforms
indicate a high degree of structural similarity and conser-
vation during vertebrate evolution (7). In the mammalian
tissues, four genes encoding for PFKFB isoenzymes have
been described: PFKFB1 (8), PFKFB2 (9), PFKFB3 (10), and
PFKFB4 (11). PFKFB1 gives rise from distinct promoters to
the L, M, and F mRNAs, which differ by their 5 end (8, 12,
13). The L isoform of PFKFB is the main isoenzyme in liver.
Nutritional and hormonal factors control the hepatic expres-
sion of the PFKFB1 gene. Glucocorticoids stimulate PFKFB1
gene transcription in rat liver, whereas glucagon promotes
the opposite effect. The effects of insulin depend on the
hormonal context. Insulin treatment increases the in vitro
rate of transcription, whereas it inhibits and reverses the
glucocorticoid-induced stimulation of transcription of the
liver PFKFB1 (5, 14, 15). The basal activity of the L promoter
is controlled by a glucocorticoid-response unit and was
found to depend on its binding of both ubiquitous (nuclear
factor 1 and octamer-binding factor 1) and liver-specific
(hepatocyte nuclear factors 3 and 6 and CCAAT/enhancer
binding protein) transcription factors (16, 17). Glucose also
stimulates the expression of PFKFB1. Although a region of
the gene, located between the F and L promoters, behaves as
a glucose-sensitive enhancer of both the F and the L pro-
moters (18), the transcription factors involved in the glucose
effect have not been identified. No modulation of PFKFB1
mRNA levels was reported to occur as a result of starvation
or diabetes (19, 20). Nevertheless, refeeding increases
PFKFB1 mRNA abundance, and a decrease in PFKFB1 ex-
pression has recently been reported in lean and obese rats
during starvation (19–21).
Insulin regulates glucose and lipid metabolism in the liver
through increasing glycolysis, glycogenesis, and lipogenesis.
Sterol regulatory element binding protein (SREBP)-1 is a
transcription factor that plays a major role in the control of
glucose and lipid homeostasis by insulin (22). SREBPs are
members of a basic-helix-loop-helix leucine zipper family of
transcription factors (23–25). SREBPs are synthesized as pre-
cursors that contain two membrane-spanning domains that
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bind them to the endoplasmic reticulum and the nuclear
membrane. After proteolytic cleavage, mature SREBPs
dimerize, enter the nucleus, and transactivate the target
genes by binding to sterol regulatory element (SRE) (26) or
E-box sequences (27). Various isoforms of SREBPs from two
genes have been identified. SREBP-1a and -1c are encoded
from a single gene, whereas a distinct gene encodes SREBP-2
(28, 29). The use of alternative promoters generates SREBP-1a
and -1c, which differ in their first exon. Both isoforms have
the same DNA binding domain and thus recognize the same
DNA element. Transcriptional activity of SREBP-1a is stron-
ger than that of SREBP-1c in cultured cells (30) and liver (31,
32). SREBP-1a is a potent activator of all SREBP-responsive
genes, whereas the roles of SREBP-1c and SREBP-2 are more
restricted. SREBP-1c preferentially activates genes required
for fatty acid synthesis, and SREBP-2 activates genes asso-
ciated with cholesterol synthesis or uptake (33). The het-
erodimer SREBP-1ac has been recently identified; it is ex-
pressed at lower levels than SREBP-1a or SREBP-1c.
Although the physiological significance of SREBP-1ac re-
mains unclear, it may be involved in transcriptional repres-
sion of SREBP function (34). It is well known that SREBP-1
plays a crucial role in the dietary regulation of most hepatic
lipogenic genes (35, 36). However, recent findings indicate
that SREBP-1 may have an important role not only in the
regulation of lipid metabolism but also in glucose metabo-
lism (37). SREBP-1c interacts in vivo with the promoter of
hexokinase II and mediates the action of insulin on hexoki-
nase II and glucokinase transcription in liver (38–41). On the
other hand, overexpression of SREBP-1a in transgenic mice
shows it has a role as negative regulator of gluconeogenic
genes through suppression of phosphoenolpyruvate car-
boxykinase and glucose-6-phosphatase transcriptional acti-
vation mediated by hepatocyte nuclear factor-4 (42). De-
spite these recent findings, involvement of SREBP-1 proteins
in transactivation of PFKFB1 has not been studied.
In the present study, we show that SREBP-1a binds to a
SRE box and transcriptionally activates Sparus aurata liver
PFKFB1. In addition, we provide evidence that SREBP-1a is




Gilthead sea bream (S. aurata) obtained from Tinamenor (Cantabria,
Spain) were maintained at 20 C in 260-liter aquaria supplied with run-
ning seawater in a closed system with an active pump filter and UV
lamps. The photoperiod was a 12-h dark, 12-h light cycle. Fish were fed
daily (1000 h) at 1% body weight with a diet containing 46% protein, 9.3%
carbohydrates, 22% lipids, 10.6% ash, 12.1% moisture, and 21.1 kJ/g
gross energy. To study regulation of SREBP-1 expression by insulin and
glucose in vivo, the animals were divided into three groups of six fish
each. Twenty-four hours after the last meal (1000 h), two different groups
received an ip injection of glucose (2 g/kg fish) or bovine insulin (10
U/kg fish; Sigma, St. Louis, MO). The other group was injected with
vehicle (saline). Fish were killed by cervical section 6 h after treatment.
The effect of nutritional status was studied in fish starved for 17 d and
then allowed to refeed for 9 h. Tissue samples were dissected out,
immediately frozen in liquid N2, and kept at 80 C until use. To avoid
stress, fish were anesthetized with MS-222 (1:12,500) before handling.
The experimental procedures met the guidelines of the animal use com-
mittee of the Universitat de Barcelona.
Cloning of the 5-flanking region of PFKFB gene from S.
aurata by chromosome walking
The 5-flanking region of fish PFKFB1 was isolated by PCR using the
Universal GenomeWalker Kit (CLONTECH, Palo Alto, CA). Briefly, four
libraries were obtained by blunt-end digestion of S. aurata genomic DNA
with DraI, EcoRV, PvuII, and StuI. Each batch of digested genomic DNA
was ligated to the GenomeWalker adaptor provided in the kit. A pri-
mary PCR was performed on each library with the gene-specific primer
PF02 (Table 1) and the AP-1 primer provided in the kit. Seven initial
cycles were carried out, with 25 sec of denaturation at 94 C and 3 min
of annealing and extension at 72 C, followed by 32 cycles with 25 sec of
denaturation and 3 min of annealing and extension at 72 C. A nested PCR
was performed on the primary PCR product using the gene-specific
primer PF01 (Table 1) and the AP2 primer from the kit. Five cycles were
carried out, with 25 sec of denaturation at 94 C, 30 sec of annealing at
60 C, and 3 min of extension at 72 C, followed by 20 cycles with 25 sec
of denaturation at 94 C, 30 sec of annealing at 55 C, and 3 min of extension
at 72 C. The longer amplification product, a single 2.5-kb band obtained
from the EcoRV library, was ligated into pGEM-T Easy plasmid (Pro-
mega, Madison, WI) to generate pGEM-P2500. Two independent clones
were fully sequenced on both strands after the ABI Prism BigDye Ter-
minator Cycle Sequencing Ready Reaction kit instructions (Applied
Biosystems, Foster City, CA).
Characterization of the transcription start site
The 5 end of the hepatic S. aurata PFKFB1 cDNA was determined
using the SMART RACE cDNA Amplification Kit (CLONTECH). This
TABLE 1. S. aurata PFKBP1 gene-specific primers used in the present study
Primer (5–3) Maps to
PF01 TTGTGTTCCTGACATGGC 96 to 79
PF02 CCCAGGTCTTCTCCAGAGGGTTC 133 to 111
PF03 TGCCCGGGTGCATCAGCCTCCTGTTGAAC 7 to 15
PF07 CAGAGCTCCTCCCCCCCTGACATGGTTTTTGAAAGTTCAAAATCTGAACACTCG 77 to 24
PF10 ACACACTCAGCTGGCTGTTG 49 to 68
PF15 GGTGACGTGGATGTTCATG 820 to 802
PF55 GGGACGGTTAACGTGAGTGACAGG 153 to 130
PF56 AACCAGCGTCGACTCTCATC 1571 to 1552
PF57 TGGTTGGAGCTCATACACCG 1291 to 1310
PFK2-61/-41 CTGACATGGTGTGAGAAAGTT 61 to 41
PFK2-61/-41mutSRE CTGACATGGTTTTTGAAAGTT 61 to 41
The following primers contain restriction sites (indicated in bold): PF03 SmaI and PF07 SacI. Bold and underlined letters indicate
site-directedmutations in primers PF07 andPFK2-61/-41mutSRE. For double-stranded oligonucleotides PFK2-61/-41 andPFK2-61/-41mutSRE
used in gel shift experiments, only the forward primers are shown. Mapping positions for PF10 and PF15 are calculated from S. aurata PFKFB1
cDNA. For other primers, mapping positions are calculated from S. aurata PFKFB1 gene relative to the transcription start site.
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approach generates full-length cDNAs in RT reactions (43). To this end,
1 g of poly A RNA obtained from liver of S. aurata was converted into
cDNA using PowerScript RT at 42 C for 1.5 h. 5-RACE ready cDNA was
obtained using the 5-CDS primer, for first-strand synthesis, and the
SMART II A oligonucleotides from the kit. After reaching the end of the
mRNA template, the terminal transferase activity of PowerScript RT
adds several dC residues that allow annealing of the SMART II A
oligonucleotide, which serves as an extended template for RT. A touch-
down PCR was conducted with the Universal Primer Mix A from the kit
and PF02 oligonucleotides. Five initial cycles were carried out, with 30
sec of denaturation at 94 C and 3 min of annealing and extension at 72
C, followed by five cycles with 30 sec of denaturation at 94 C, 30 sec of
annealing at 70 C, and 3 min of extension at 72 C, and 20 cycles with 30
sec of denaturation at 94 C, 30 sec of annealing at 68 C, and 3 min of
extension at 72 C. A nested PCR was performed with the Nested Uni-
versal Primer from the kit and PF01 oligonucleotides. Five cycles were
carried out, with 25 sec of denaturation at 94 C, 30 sec of annealing at
60 C, and 1 min 15 sec of extension at 72 C, followed by 35 cycles with
25 sec of denaturation at 94 C, 30 sec of annealing at 55 C, and 1 min 15
sec of extension at 72 C. The single 126-bp band generated was purified
and ligated into pGEM-T Easy plasmid (Promega). Identical nucleotide
sequence corresponding to the 5 end of PFKFB cDNA was obtained by
sequence analysis of two independent clones.
RT-PCR analysis of PFKFB1 mRNA tissue specificity
cDNA templates for PCR amplification were synthesized from 5 g
total RNA obtained from S. aurata frozen tissues using Moloney murine
leukemia virus RT (Invitrogen, Carlsbad, CA) for 60 min at 37 C in the
presence of random hexamer primers. The RT reaction products were
subjected to PCR amplification using PF10 and PF15 as primers (Table
1) to amplify a 772-bp fragment of S. aurata PFKFB1 cDNA. As a control
of RNA integrity, a 711-bp fragment of S. aurata -actin was amplified
in parallel with primers BA0199 (5-GACAACGGATCCGGTATGTGC-
3) and BA0299 (5-GACCTGTCCGTCGGGCAGCTC-3). After initial
denaturation at 94 C for 2 min, 30 cycles were carried out, with 30 sec
of denaturation at 94 C, 30 sec of annealing at 60 C, and 2 min of extension
at 72 C. Aliquots of each reaction were electrophoresed on a 1% agarose
gel and visualized by ethidium bromide staining.
Construction of reporter gene plasmids
The S. aurata PFKFB1 promoter sequence located between positions
2130 and 66 relative to the transcription start site was obtained by
PvuII digestion of pGEM-P2500 and subcloned into the SmaI site of the
promoterless luciferase reporter plasmid pGL3-Basic (Promega) to gen-
erate pGPFK2130. The reporter constructs designated as pGPFK213,
pGPFK132, and pGPFK2130125 were produced by self-ligation of
filled-in ends of pGPFK2130 after digestion with NheI/SmaI, NheI/
BstEII, and BstEII/HindIII, respectively. Self-ligation of pGPFK2130
previously digested with NheI/SpeI and SacI was performed to gen-
erate pGPFK666 and pGPFK75, respectively. The pGPFK7 and
pGPFK75mutSRE constructs were generated by PCR amplification us-
ing pGPFK2130 as template, and primer pairs PF03 (with a 5-anchor
sequence containing a SmaI site; Table 1)/GLprimer2 and PF07 (with a
mutated SRE box and a 5-anchor sequence containing a SacI site; Table
1)/GLprimer2, respectively. The PCR products were subcloned into the
SmaI/HindIII and SacI/HindIII sites, respectively, of pGPFK2130. The
pGPFK1302 and pGPFK1302mutSRE constructs were made by ligation
of the SacI/SacI PFKFB promoter fragment, obtained from pGPFK2130,
to previously SacI-digested and dephosphorylated pGPFK75 and
pGPFK75mutSRE, respectively. All constructs were verified by sequenc-
ing using ABI Prism BigDye Terminator Cycle Sequencing Ready Re-
action kit (Applied Biosystems).
Cell transfection and luciferase assay
The human hepatoma-derived cell line HepG2 (ATCC HB 8065) was
cultured in DMEM supplemented with 10% fetal bovine serum, 100
IU/ml penicillin, 100 g/ml streptomycin, and 2 mm glutamine. The
cells were grown at 37 C in 5% CO2. The calcium phosphate coprecipi-
tation method was used for transient transfection of HepG2 at 45–50%
confluence in six-well plates (44). Cells were transfected with 4 g of the
reporter construct and with 400 ng of the expression vector encoding
SREBP-1a. To correct for variations in transfection efficiency, 500 ng of
CMV- plasmid (lacZ) was included in each transfection. To ensure
equal DNA amounts, empty plasmids were added in each transfection.
Four hours after addition of the precipitate, cells were shocked in 10%
dimethylsulfoxide in serum-free medium for 2 min. The cells were
harvested 16 h later, washed in PBS, and incubated for 15 min in 300 l
of Cell Culture Lysis Reagent (Promega). After removal of cell debris by
centrifugation at 10,000  g for 15 sec, luciferase activity was measured
in the supernatant after addition of Luciferase Assay Reagent (Promega)
in a TD-20/20 Luminometer (Turner Designs, Sunnyvale, CA). -
Galactosidase activity of 30–100 l of the clear lysate was measured in
a 1-ml reaction containing 0.3 mm MgCl2, 13.5 mm -mercaptoethanol,
0.9 mm 2-nitrophenyl--d-galactopyranoside, and 0.1 m sodium phos-
phate (pH 7.5). After incubation at 37 C (usually 20 min to 1 h), the
reaction was stopped by addition of 0.5 ml of 0.5 m Na2CO3, and the
intensity of the yellow color was determined by its OD at 420 nm. The
expression plasmid encoding SREBP-1a (pSG5-SREBP-1a) was kindly
provided by Dr. D. Haro (Departament de Bioquı´mica i Biologia Mo-
lecular, Universitat de Barcelona, Barcelona, Spain).
EMSA
Double-stranded oligonucleotides used in gel-shift experiments were
SRE-cons (5-ATCCTGATCACGTGATCGAGGAG-3; only the forward
oligonucleotide is shown), PFK2–61/-41, and PFK2–61/-41mutSRE,
which contains a mutated SRE box (Table 1), and 200 pmol of the
double-stranded oligonucleotides were 3-end labeled with digoxige-
nin-11-ddUTP by using terminal transferase (Roche, Basel, Switzerland)
in a 20-l reaction for 30 min at 37 C. The reaction was stopped by adding
2 l of 0.2 m EDTA. Binding reactions were carried out in a total volume
of 20 l containing 100 mm HEPES (pH 7.6), 5 mm EDTA, 50 mm
(NH4)2SO4, 5 mm dithiothreitol, 1% Tween 20, 150 mm KCl, 1 g of
nonspecific competitor polydeoxyinosinic deoxycytidylic acid (Roche),
nuclear extracts of HepG2 cells overexpressing SREBP-1a, and the la-
beled probe. The DNA-protein complexes were electrophoresed at 4 C
on 5% polyacrylamide gel and using 0.5 Tris-borate-EDTA as buffer.
DNA was thereafter transferred by contact blotting (2 h at room tem-
perature) to Nytran membranes (Schleicher & Schuell, Keene, NH).
DNA was cross-linked to membranes by UV irradiation for 3 min.
Labeled probes were immunodetected with antidigoxigenin conjugated
to alkaline phosphatase (Roche) and using CDP-Star (Roche) as chemi-
luminescent substrate. Membranes were finally exposed to Hyperfilm
ECL (Amersham, Piscataway, NJ). For competition experiments, HepG2
extracts were preincubated for 30 min with a 200-fold molar excess of
unlabeled double-stranded SRE-cons oligonucleotide. For supershift as-
says, 2 g of anti-SREBP-1 (Santa Cruz Biotechnology, Santa Cruz, CA)
were incubated with nuclear proteins extracted from SREBP-1a-over-
expressing HepG2 cells for 30 min at room temperature before addition
of the probe.
Nuclear extracts
Nuclear extracts were prepared from HepG2 cells as described by
Andrews and Faller (45) with minor modifications. Cells were grown to
near confluency, washed, and scraped into 1.5 ml of cold PBS. All the
following steps were performed at 4 C. The cells were pelleted by
centrifugation for 10 sec at 1000 g and resuspended in 400 l of buffer
A [10 mm HEPES-KOH (pH 7.9), 1.5 mm MgCl2, 10 mm KCl, 0.5 mm
dithiothreitol, and 0.2 mm phenylmethylsulfonyl fluoride]. After incu-
bation for 10 min, cells were vortexed for 10 sec. Samples were centri-
fuged for 10 sec, and the pellet was resuspended in 20 l of cold buffer
C [20 mm mM HEPES-KOH (pH 7.9), 25% glycerol, 420 mm NaCl, 1.5
mm MgCl2, 0.2 mm EDTA, 0.5 m dithiothreitol, and 0.2 mm phenyl-
methylsulfonyl fluoride] and incubated 20 min for high-salt extraction.
Cellular debris was removed by centrifugation for 2 min. The super-
natant fraction was aliquoted and stored at 80 C.
Chromatin immunoprecipitation (ChIP) assay
To obtain chromatin extracts, S. aurata livers were fixed with 1%
formaldehyde in serum-free DMEM for 15 min. After neutralization
with 1.5m glycine, the minced livers were homogenized and centrifuged
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at 1500 rpm for 1 min. The pellet was resuspended in cell lysis buffer [5
mm piperazine-1,4-bis(2-ethanesulfonic acid) (pH 8.0), 85 mm KCl, 0.5%
Nonidet P-40, 0.075 mmphenylmethylsulfonyl fluoride, and 1protease
inhibitors cocktail], incubated at 4 C for 10 min, and centrifuged at
4000 g for 5 min. The sediment was resuspended in nuclei lysis buffer
[50 mm Tris-HCl (pH 8.1), 10 mm EDTA, 1% sodium dodecyl sulfate,
0.075 mm phenylmethylsulfonyl fluoride, and 1 protease inhibitors
cocktail] and incubated at 4 C for 10 min. Chromatin was sonicated to
an average size of 100–600 bp. At this step, one aliquot containing 30 g
chromatin was retained and used as a positive control (input) after
reversal of the cross-linking reaction. To reduce nonspecific background,
chromatin samples (100 g) were precleared with 20 l protein A/G-
agarose beads (Santa Cruz Biotechnology). The beads were pelleted, and
chromatin complexes in the supernatant were immunoprecipitated
overnight at 4 C with 8 g anti-SREBP-1 (Santa Cruz Biotechnology) or
anti-Sp3 (Santa Cruz Biotechnology) or without antibody. Immune com-
plexes were incubated for 2 h at 4 C with 20 l protein A/G-agarose
beads, washed extensively, and eluted. Cross-links of eluted and input
chromatins were reversed by incubation with 0.4 mg/ml proteinase K
for 2 h at 37 C and overnight at 65 C. Purified DNA fragments were
analyzed with 35 cycles of PCR using S. aurata PFKFB1-specific primer
pairs PF55/PF02 and PF56/PF57, which amplify promoter sequences
spanning nucleotides 153 to 133 and 1571 to 1290 relative to the
transcription start site, respectively (Table 1). Nutritional and hormonal
regulation of SREBP-1 association to PFKFB1 promoter in S. aurata liver
samples was tested by semiquantitative PCR of immunoprecipitated
chromatin with anti-SREBP-1. ChIP products were subjected to PCR
amplification using PF55 and PF02 as primers. After initial denaturation
at 94 C for 2 min, a number of cycles between 20 and 35 at 94 for 30 sec,
60 C for 30 sec, and 72 C for 50 sec were performed to verify that the PCR
products amplify linearly and to determine the optimal number of cycles
allowing their detection without saturation of the signal. Aliquots of
each reaction were electrophoresed on a 1% agarose gel, and band
intensities were compared by imaging of ethidium bromide staining.
Western blotting analysis
One hundred micrograms of protein were loaded per lane of a 10%
polyacrylamide gel for electrophoresis in the presence of sodium do-
decyl sulfate (SDS-PAGE). After electrophoresis, the gel, equilibrated in
transfer buffer (25 mm Tris, 192 mm glycine, 20% methanol, pH 8.3), was
electroeluted onto NytranN nylon membranes (Schleicher & Schuell) at
60 V for 3 h at 4 C. A polyclonal antihuman SREBP-1 (1:200) (Santa Cruz
Biotechnology) was used as primary antibody to detect SREBP-1 in liver
extracts of S. aurata after the ECL Western blotting (Amersham)
procedure.
Northern blotting analysis
Total RNA was isolated from liver samples of S. aurata with the Total
Quick RNA Cells & Tissues kit (Talent, Trieste, Italy). Twenty micro-
grams of total RNA were denatured and then loaded onto a 1% agarose
gel containing 4.75% formaldehyde. Electrophoresis was performed in
denaturing conditions for 5 h at 35 V; RNA was then transferred over-
night to NytranN membranes (Schleicher & Schuell) in 5 standard
saline citrate (SSC) (1 SSC contains 150 mm NaCl, 15 mm sodium
citrate, pH 7.5). RNA was cross-linked to the membranes by UV irra-
diation for 3 min. A PFKFB1 homologous probe was labeled by incor-
poration of digoxigenin-11-dUTP during PCR with primer pair PF11/
PF12. Prehybridizations of the membranes proceeded for 2 h at 50 C in
7% SDS (wt/vol), 50% formamide, 5 SSC, 2% blocking reagent (Roche),
0.1%N-laurylsarcosine (wt/vol), 50 mm sodium phosphate (pH 7.0). The
probes were added, and hybridization was performed overnight at 50
C. Membranes where then washed twice for 15 min at room temperature
in 2 SSC, 0.1% SDS and twice for 15 min at 68 C in 0.2 SSC, 0.1% SDS,
and 18 S rRNA was used to correct for loading irregularities. Labeled
probes were immunodetected with antidigoxigenin conjugated to al-
kaline phosphatase (Roche) and CDP-Star (Roche) as chemiluminescent
substrate. Membranes were finally exposed to Hyperfilm ECL
(Amersham).
Statistics
Data were analyzed by one-factor ANOVA using a computer pro-
gram (StatView; SAS Institute, Cary, NC). Differences were determined
by Fisher’s protected least-significant difference multiple-range test,
with significance levels at P  0.05 and P  0.01.
Results
Cloning of the 5-flanking region of the S. aurata
PFKFB1 gene
A 2269-bp fragment upstream from the translation start
codon of PFKFB1 was isolated by chromosome walking on
S. aurata genomic DNA using oligonucleotides designed
from the piscine hepatic PFKFB cDNA (Fig. 1A). The putative
transcription initiation site of PFKFB1 mRNA was deter-
mined using the SMART RACE PCR approach (Fig. 1B). A
single fragment was obtained and cloned into pGEM-T Easy.
Upon sequencing, this fragment exhibited complete homol-
ogy to the 70 bases in the 5 untranslated region of the
previously cloned S. aurata PFKFB1 cDNA (46). Analysis of
two independent clones indicated that S. aurata PFKFB1
mRNA initiates 81 nucleotides upstream from the translation
start codon. Sequence analysis of the 2269-bp 5-flanking
region using TRANSFAC (47), revealed the presence of sev-
eral putative transcription factor binding sites. Among the
potential transcription factors were sites for Oct-1, hepato-
cyte nuclear factor 3, and CCAAT/enhancer binding pro-
tein proteins, all implicated in transactivation of rat liver
PFKFB1 (Fig. 1A). Two SRE-like boxes were also found, al-
though involvement of SREBP-1 in PFKFB1 expression has
not been addressed before.
Tissue specificity of PFKFB1 expression was assessed by
RT-PCR in various tissues of S. aurata. As shown in Fig. 1C,
liver is the tissue with the highest PFKFB1 mRNA abun-
dance. Weak signals were detected in kidney and intestine,
whereas barely detectable levels were found in skeletal mus-
cle, brain, and spleen.
Functionality of S. aurata PFKFB1 promoter
To determine whether the genomic DNA flanking exon 1
contains a functional promoter, the DNA fragment isolated
by chromosome walking was subcloned in the promoterless
plasmid pGL3-Basic, upstream from the luciferase reporter
gene. The recombinant plasmid pGPFK2130 (2130/66)
was transiently cotransfected into HepG2 cells together with
a lacZ-containing plasmid, as internal control for transfection
efficiency. This construct exhibited more than a 240-fold in-
crease in luciferase activity relative to the promoterless vec-
tor, pGL3-Basic (Fig. 2). This result indicated that the region
comprised within 2130 nucleotides upstream from the tran-
scription start site of S. aurata PFKFB1 contains a functional
promoter.
To examine the promoter functional regions involved in
modulation of basal PFKFB1 expression in S. aurata, sequen-
tial 5-deletion analysis of the promoter fragment was carried
out. Deletion fragments, with 5 ends ranging from2130 to
7 and 3 ends at 66, were fused to the luciferase reporter
gene and transfected into HepG2 cells. The longest 5 con-
struct (pGPFK2130, 2130 to 66) yielded a 240-fold in-
crease in luciferase activity relative to pGL3-Basic (Fig. 2).
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FIG. 1. Sequence analysis of the 5-flanking region, mapping of the transcription initiation site, and tissue distribution of S. aurata PFKFB1.
A, The upstream sequence isolated by chromosome walking is shown in capitals. An arrow indicates the transcription start site. The translation
start codon is in bold. Putative binding sites for transcription factors are boxed. B, Resolution of SMART RACE PCR products on a 4% agarose
gel is shown. The assay, performed with 1 g hepatic poly A RNA (lane 3), produced a 126-bp band that was purified, ligated into pGEM-T
Easy, and sequenced. Negative controls using Nested Universal Primer or PF01 oligonucleotides alone are shown in lanes 1 and 2, respectively.
C, RT-PCR detection of PFKFB1 messenger in various tissues of S. aurata. Total RNA obtained from liver (L), brain (B), skeletal muscle (M),
heart (H), intestine (I), kidney (K), spleen (S), and gill (G) was reverse transcribed and submitted to PCR using specific primers for PFKFB1
(top) or -actin as an internal control for quality and quantity of RNA (bottom). PCR products were size fractionated by electrophoresis on a
1% agarose gel and visualized by ethidium bromide staining.
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Sequential 5-deletion of pGPFK2130 resulted in a gradual
decrease of basal activity. The construct pGPFK132 (132 to
66) still showed a 30-fold induction of promoter activity.
No activity was found using the smallest construct (pGPFK7;
7 to 66). The promoter activity decreased to approxi-
mately 57% by deletion of the sequences within the region
125 to 66 (pGPFK2130125). These results indicate that
the minimal core promoter of the S. aurata PFKFB1 gene
locates in the region within 132 bp upstream from the tran-
scriptional start and suggests that cis-acting elements may be
located in this region. Because the promoter sequence of
piscine PFKFB1 presents two putative SRE-like boxes and
SREBP-1 has been recently involved in transcriptional reg-
ulation of several regulatory enzymes of glycolysis-glucone-
ogenesis, we addressed the effect of SREBP-1a on the pro-
moter activity of PFKFB.
Transactivation of PFKFB1 promoter by SREBP-1a
To examine the role of putative SRE boxes (located at
positions171/163 and56/48 relative to the transcrip-
tion start site) in the transcriptional activity of the PFKFB1
gene, cotransfection experiments in HepG2 cells were per-
formed. Reporter constructs containing 5-deletion analysis
of the promoter fragment were introduced into HepG2 cells
together with expression plasmids encoding SREBP-1a. Co-
transfection of SREBP-1a with reporter constructs equal or
longer than pGPFK75 resulted in a 4- to 7-fold induction of
the promoter activity relative to the basal activity of the
corresponding promoter constructs. No enhancement of the
promoter activity could be detected when the shortest con-
struct (pGPFK7) was used. These results suggest that a func-
tional SREBP binding site may be located within 75 bp up-
stream from the transcription start site. Furthermore, no
transactivation by SREBP-1a was observed when cotrans-
fected with pGPFK2130125 reporter construct, which lacks
the region within 125 bp upstream from the transcriptional
start (Fig. 3). These results allowed us to discard the SRE box
at171/163, and thus we addressed the binding and trans-
activating action of SREBP-1a on the SRE box at 56/48.
SREBP-1a binds to the putative SRE site of
PFKFB1 promoter
The shorter reporter construct that exhibited SREBP-
mediated transactivation (pGPFK75) contains a SRE box at
positions 56 to 48 relative to the transcription start site.
To show that SREBP-1a can indeed bind to the putative SRE
box at position 56 to 48, bandshift experiments were
performed. Using probe PFK2–61/-41 (harboring the puta-
tive SRE box) and nuclear extracts prepared from HepG2
cells overexpressing SREBP-1a, one major shifted band could
be observed. A DNA-protein complex with the same mobil-
ity was observed when a consensus SREBP probe was used
(SRE-cons). The shifted band disappeared by competition
with 200-fold molar excess of unlabeled SRE-cons (Fig. 4A).
In addition, the SREBP-1 antibody completely blocked the
binding of SREBP-1 to the probe (Fig. 4B). These data confirm
that SREBP-1a binds to the SRE box at positions 56 to 48
of PFKFB1.
To test whether mutations in the putative SRE site could
FIG. 3. Effect of SREBP-1a on S. aurata PFKFB1 promoter tran-
scription in HepG2 cells. The cells were transfected with pGL3-Basic
or the promoter construct pGPFK2130, pGPFK1302, pGPFK666, pG-
PFK213, pGPFK132, pGPFK75, or pGPFK7, with or without an ex-
pression plasmid encoding SREBP-1a. The promoter activity of the
constructs alone was set at 1. The data represent the mean  SD
values of three independent duplicate experiments.
FIG. 2. Functional analysis of the 5-flanking region of PFKFB1 in HepG2 cells. The top left part represents the genomic organization of the
5-flanking region of S. aurata PFKFB1. Relevant restriction sites and exon 1, depicted as a white box, are indicated. Nucleotide numbering
starts with 1 corresponding to the transcriptional start. Reporter constructs having varying 5 ends and an identical 3 end (66), except for
pGPFK2130125, were transfected in HepG2 cells. Luciferase activity is expressed as a fold increase over promoterless reporter plasmid
pGL3-Basic. Results presented are the mean  SD from at least three independent duplicate experiments.
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abolish formation of the DNA-protein complex, we per-
formed bandshift assays using nuclear extracts of HepG2
cells overexpressing SREBP-1a and a labeled probe harbor-
ing positions 61 to 41 of the PFKFB1 gene in which the
SRE box was mutated (PFK2-61/-41mutSRE). As shown in
Fig. 4C, the complex shifted using SRE-cons, and PFK2-
61/-41 probes totally disappeared when the PFK2-61/-
41mutSRE probe was used.
Mutating the SRE box abolishes transactivation by
SREBP-1a
To generate reporter constructs with a mutated SRE site
(pGPFK1302mutSRE and pGPFK75mutSRE), the same mu-
tations described for the double-stranded oligonucleotide
PFK2-61/-41mutSRE in bandshift assays were introduced
into the promoter constructs pGPFK1302 and pGPFK75, re-
spectively. Cotransfection experiments with these promoter
constructs and expression vectors for SREBP-1a were per-
formed in HepG2 cells to compare transactivation of the
wild-type and mutated reporter constructs. SREBP-1a was
not able to enhance the transcription of the constructs har-
boring the mutated SRE box (Fig. 5). From this we concluded
that the SRE site at position56 to48, relative to the major
transcription start site of the S. aurata PFKFB1 promoter, is
responsible for transactivation by SREBP-1a.
SREBP-1 binds to the SRE box on the S. aurata PFKFB1
promoter in vivo
To investigate association of SREBP-1 to the SRE box on the
S. aurata PFKFB1 gene promoter in vivo, ChIP experiments
were conducted. After cross-linking, chromatin was sheared
by sonication. DNA-protein complexes were immunopre-
cipitated with antibodies against SREBP-1 or Sp3 (negative
control) or without antibody (negative control). PCR analysis
with primers spanning nucleotides 153 to 133 relative to
the transcription start site, which comprise the SRE box (56
to 48), showed that SREBP-1 associates with PFKFB1 pro-
moter in vivo (Fig. 6). No binding was observed with a dif-
ferent antibody (anti-Sp3) or no antibody or using oligonu-
cleotides to amplify an upstream region (1571/1290) of
the PFKFB1 promoter. These findings indicate that the SRE
box on the PFKFB1 promoter is a functional SREBP-1 binding
site in vivo.
Nutritional and hormonal regulation of SREBP-1 and
PFKFB1 gene expression in liver of S. aurata
The observations that SREBP-1a binds to and transacti-
vates PFKFB1 promoter prompted us to study the role of this
transcription factor in the hepatic expression of PFKFB1 un-
der different nutritional and hormonal conditions. To this
end, we analyzed the protein levels of SREBP-1, SREBP-1
occupancy of PFKFB1 promoter, and PFKFB1 mRNA abun-
dance in the liver of S. aurata during the starved-to-fed tran-
sition, and in glucose- and insulin-treated animals. Western
blot analysis using antibodies against SREBP-1 showed that
starvation resulted in hardly immunodetectable levels of the
FIG. 4. Electrophoretic mobility shift assay. A, Competition analysis
using nuclear extracts of HepG2 cells overexpressing SREBP-1a in-
cubated with labeled oligonucleotide SRE-cons (lanes 1–3) or PFK2-
61/-41 (lanes 4–6). Lanes 1 and 4 contained no extract. Lanes 2 and
5 show binding of nuclear extracts to labeled probes without com-
petitor. Lanes 3 and 6 show competition with 200-fold molar excess
of unlabeled double-stranded competitor (SRE-cons). B, Supershift
analysis using nuclear extracts of HepG2 cells overexpressing
SREBP-1a incubatedwith labeled oligonucleotide PFK2-61/-41 (lanes
1–3) or SRE-cons (lanes 4–6). Lanes 1 and 4 contained no extract.
Binding of nuclear extracts to labeled probes are shown in the absence
(lanes 2 and 5) or presence of antibody (Ab) against SREBP-1 (lanes
3 and 6). C, Shift assays performed using nuclear extracts of HepG2
cells incubated with labeled oligonucleotides SRE-cons, PFK2-61/-41,
or PFK2-61/-41mutSRE (mutated SRE box). DNA-protein complexes
are indicated by arrows. NE, Nuclear extracts.
FIG. 5. Effect of SREBP-1a on the promoter activity of PFKFB1 con-
taining a mutated SRE box. pGPFK1302, pGPFK1302mutSRE,
pGPFK75, pGPFK75mutSRE, pGPFK2130125, and pGPFK7 were
cotransfected inHepG2 cells alongwith an expression vector encoding
SREBP-1a. The luciferase activity of the reporter constructs alone
was set at 1. The data represent the mean  SD values of three
independent duplicate experiments.
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mature form of SREBP-1 (68 kDa). Refeeding for 9 h in-
creased values for both precursor (125 kDa) and mature
forms of SREBP-1 protein (Fig. 7A). ChIP and Northern blot-
ting assays showed that starvation reduced SREBP-1 binding
to PFKFB1 promoter and decreased PFKFB1 mRNA levels in
the piscine liver, whereas both SREBP1 binding and PFKFB1
mRNA partially recovered the values observed in fed fish 9 h
after refeeding (Fig. 7, B and C).
Concerning regulation of SREBP-1 by nutrients and hor-
mones, a rise in precursor and mature SREBP-1 protein levels
was observed 6 h after treatment with glucose or insulin (Fig.
8A). Changes in in vivo association of SREBP-1 to PFKFB1
promoter were monitored by means of ChIP analysis in the
liver of S. aurata. Treatment with glucose or insulin increased
SREBP-1 occupancy of PFKFB1 promoter (Fig. 8B). Analysis
of Northern blots showed increased PFKFB1 mRNA levels in
the piscine liver 6 h after treatment with insulin and, to a
lesser extent, with glucose (Fig. 8C).
Discussion
In this study, we have identified SREBP-1 as a new factor
implicated in the induction of PFKFB1 expression by nutrient
and hormonal conditions. To study transcriptional regula-
tion of PFKFB1, we isolated and characterized the promoter
region of PFKFB1 from the liver of S. aurata. The genomic
fragment isolated is the first PFKFB gene promoter reported
for nonmammalian animals, and it allowed us to identify a
SRE box in the proximal region of the PFKFB1 promoter
implicated in transactivation by SREBP-1a. The 5-flanking
region of S. aurata PFKFB1 was cloned by chromosome walk-
ing. Mapping of the transcriptional start indicated the pres-
ence of a start site located 81 bp upstream from the trans-
lation start codon. Evaluation of tissue distribution of
PFKFB1 mRNA in S. aurata indicates that PFKFB1 mRNA is
mainly expressed in liver. The functionality of the putative
promoter region of fish PFKFB1 was tested by transient
transfection of HepG2 cells with fusion constructs of the
5-flanking 2269 bp isolated by chromosome walking and
sequential 5 deletions of this fragment to the luciferase gene.
We found that the promoter region within 132 bp upstream
FIG. 7. Effect of starvation and refeeding on SREBP-1 pro-
tein levels, SREBP-1 binding to PFKFB1 promoter, and
PFKFB1 mRNA levels in the liver of S. aurata. A, A rep-
resentative Western blot shows the amount of immunode-
tectable SREBP-1 protein in liver samples from fed, 17-d-
starved and 9-h-refed fish. The arrows indicate the position
of immunodetectable precursor (125 kDa) and mature
(68 kDa) forms of SREBP-1. B, Representative ChIP anal-
ysis of SREBP-1 association to PFKFB1 promoter in liver
of fed, 17-d-starved and 9-h-refed fish. Purified DNA from
immunoprecipitated chromatin with anti-SREBP-1 was
analyzed by semiquantitative PCR using primer pairs to
specifically amplify nucleotides 153/133 relative to the
transcription start site of PFKFB1 gene promoter. C, Rep-
resentative Northern blot of PFKFB1 mRNA levels in liver
of fed, 17-d-starved and 9-h-refed fish. Twenty micrograms
of total RNA was loaded in each lane. The integrity and
relative amounts of RNA loaded were checked and cor-
rected by 18S rRNAethidiumbromide staining on the same
gel. A–C, On the right is shown the densitometric analyses
of immunodetectable PreSREBP-1 and SREBP-1 (A), ChIP
analysis (B), and PFKFB1 mRNA levels (C) as arbitrary
units  SD of three to four liver samples. Statistical signif-
icance related to fed animals is indicated as follows: *, P 
0.05; **, P  0.01.
FIG. 6. SREBP-1 associates with PFKFB1 promoter in vivo. A ChIP
assay was performed on S. aurata liver. Schematic drawing of S. aurata
PFKFB1 gene promoter, location of the PCR primers (arrows), and se-
quence of the SRE box (underlined) are shown at the top of the figure.
After cross-linking with 1% formaldehyde, chromatin was sheared by
sonication and immunoprecipitated with antibody anti-SREBP-1 or an-
ti-Sp3 or without antibody. Immunocomplexes were collected with pro-
tein A/G-agarose beads. After intensive washing, the bound DNA-com-
plexeswere eluted and reverse cross-linked. PurifiedDNAwas analyzed
byPCRusingprimerpairs to specificallyamplifynucleotides153/133
or1571/1290 relative to the transcription start site of PFKFB1 gene
promoter. ThePCRproductswere electrophoresed onanagarose gel and
visualized by ethidium bromide staining.
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from the transcription start site is essential for transcriptional
basal activity of PFKFB and thus constitutes the core func-
tional promoter of this gene. The presence of SRE-like boxes
in this region and the fact that there is increasing evidence
for involvement of SREBP-1 proteins in the transcriptional
control of several regulatory enzymes of glycolysis-glucone-
ogenesis (38–42) led us to investigate a possible role of
SREBP-1 in the transcriptional activation of PFKFB1. In this
study, we show that SREBP-1a interacts specifically with the
SRE box located between56 and48 bp upstream from the
transcription start site of S. aurata liver PFKFB1 gene pro-
moter. By means of ChIP assays we show that binding of
SREBP-1 to the S. aurata PFKFB1 promoter occurs in vivo.
Transient transfection studies carried out in HepG2 cells
allowed us to demonstrate that SREBP-1a confers an acti-
vating signal through binding to an SRE-like box in the
PFKFB1 promoter. Mutations in the SRE box abolished bind-
ing of SREBP-1a to the mutated site, and as a result, SREBP-1a
was no longer able to enhance the transcription of PFKFB1.
From these results, we clearly conclude that SREBP-1a is
implicated in the transcriptional activation of PFKFB1
promoter.
Previously, we showed that hepatic mRNA levels of S.
aurata PFKFB1 depend largely on nutritional status. Starva-
tion decreased mRNA levels of PFKFB1 in the liver of S.
aurata, whereas refeeding induces the recovery of PFKFB1
expression at the mRNA, immunodetectable protein, 6-phos-
phofructo-2-kinase activity, and Fru-2,6-P2 levels (46). Short-
term refeeding promotes a rapid recovery of the hepatic
expression of PFKFB1 and Fru-2,6-P2. Indeed, PFKFB1 ex-
pression is directly dependent on the quantity of diet sup-
plied to fish in culture, presumably because of changes in
hormonal status, particularly in the insulin/glucagon ratio
(48). Concerning dietary regulation, feeding dietary carbo-
hydrates stimulates PFKFB1 gene expression and increases
6-phosphofructo-2-kinase activity and Fru-2,6-P2 levels in
fish and mammalian liver (48–50). Because SREBP-1 abun-
dance is closely related to the nutritional state in the mam-
malian liver (32, 51), in the present study, we addressed
regulation of immunodetectable SREBP-1 levels, changes in
SREBP-1 binding to PFKFB1 promoter, and PFKFB1 mRNA
abundance by nutritional and hormonal factors in the liver
of S. aurata. As expected, starvation strongly decreased
mRNA levels of PFKFB1, whereas refeeding for 9 h promoted
a recovery of PFKFB1 mRNA to values similar to those ob-
served in fed fish. Treatment with insulin or glucose in-
creased PFKFB1 mRNA. However, insulin had a stronger
effect on PFKFB1 expression than glucose, whereas both
glucose and insulin similarly increased hepatic SREBP-1 lev-
els and binding to PFKFB1 promoter. In this regard, although
glucose and other nutrients such as amino acids are potent
modulators for secretion of insulin in animals, amino acids
are better secretagogues for insulin than glucose in most fish
species (52, 53). Conceivably, treatment with insulin gener-
ated a physiological status closer to the starved-to-fed tran-
sition than glucose alone in S. aurata. Because glucose ad-
ministration leads to increased insulin secretion in vivo, we
cannot rule out that the effect of glucose on PFKFB1 tran-
scription would be the result of increased insulin release.
Consistent with nutritional and hormonal regulation of
PFKFB1 gene expression, low levels of mature SREBP-1 and
decreased SREBP-1 binding to PFKFB1 promoter were found
in the liver of starved fish, whereas short-time refeeding and
administration of glucose or insulin to S. aurata increased
SREBP-1 binding to PFKFB1 promoter and the levels of both
precursor and mature SREBP-1. The regulation of SREBP-1
expression by nutritional status in the piscine liver follows a
pattern similar to that previously observed in rodents.
Refeeding mice high-carbohydrate/low-fat diets increased
precursor and nuclear protein forms of SREBP-1 as well as
transcript amounts for both SREBP-1a and SREBP-1c in the
liver (32, 37, 41). Similarly, in rat liver, SREBP-1a and
FIG. 8. Effect of glucose and insulin on SREBP-1 protein
levels, SREBP-1 binding to PFKFB1 promoter, and
PFKFB1 mRNA levels in the liver of S. aurata. A, Western
blotting analysis of immunodetectable precursor and ma-
ture forms of SREBP-1 in liver of fish 6 h after treatment
with saline (control), glucose (2 g/kg fish), or insulin (10
U/kg fish). B, Representative ChIP analysis of SREBP-1
association to PFKFB1 promoter in liver of fish 6 h after
treatment with saline (control), glucose (2 g/kg fish), or
insulin (10 U/kg fish). Purified DNA from immunoprecipi-
tated chromatin with anti-SREBP-1 was analyzed by semi-
quantitative PCR using primer pairs to specifically amplify
nucleotides 153/133 relative to the transcription start
site of PFKFB1 gene promoter. C, RepresentativeNorthern
blot of PFKFB1 mRNA levels in liver of fish 6 h after
treatment with saline (control), glucose (2 g/kg fish), or
insulin (10 U/kg fish). Twenty micrograms of total RNA
were loaded in each lane. The integrity and relative
amounts of RNA loaded were checked and corrected by 18
S rRNA ethidium bromide staining on the same gel. A–C,
On the right is shown the densitometric analyses of immu-
nodetectable PreSREBP-1 and SREBP-1 (A), ChIP (B), and
PFKFB1 mRNA (C) as arbitrary units SD of three to four
liver samples. Statistical significance related to saline-
treated (control) animals is indicated as follows: *,P 0.05;
**, P  0.01.
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SREBP-1c transcripts reduced their expression levels upon
fasting and increased with refeeding to reach higher levels
than in the fed group (37). In the present study, treatment
with glucose or insulin increased the levels of immunode-
tectable SREBP-1 in the piscine liver. These results are in
agreement with previous observations in rats. Insulin stim-
ulates, and cAMP inhibits, generation of transcriptionally
active SREBP-1a from its full-length precursor in rat hepa-
tocytes (54). Similarly, insulin increases SREBP-1c expression
and the abundance of the SREBP-1c precursor and mature
forms in rat liver (55, 56). Interestingly, overexpression of
SREBP-1a in transgenic mice results in hyperinsulinemia,
mild peripheral insulin resistance, and very small plasma
glucose increases after portal glucose loading because of a
large capacity for hepatic glucose uptake (57). On the other
hand, SREBP-1c mediates glucose-induced up-regulation of
lipogenic enzymes in rat skeletal muscle (58). Indeed, glucose
potentiates the insulin-dependent activating effect of
SREBP-1c on the hepatic expression of glucokinase and li-
pogenic enzymes in rat hepatocytes (39). Taken together, our
findings suggest an in vivo rise of SREBP-1 levels and in-
creased SREBP-1 association with PFKFB1 promoter in the
liver of S. aurata during the postprandial state as a result of
increased glucose and insulin plasma levels. This is consis-
tent with the effect of nutritional status on PFKFB1 mRNA
levels in the piscine liver and suggests that SREBP-1 mediates
postprandial regulation of PFKFB1 expression in the liver.
The results of the present study, together with the contri-
bution of SREBP-1 to insulin-dependent stimulation of glu-
cokinase expression and suppression of transcriptional ac-
tivation of gluconeogenic enzymes, argue for an important
role of this transcription factor in the expressional control of
key enzymes in liver glucose metabolism. In conclusion, we
identified a functional SRE box in the S. aurata liver PFKFB1
promoter and presented evidence for a new mechanism in-
volving SREBP-1a in the transcriptional regulation of
PFKFB1, a key enzyme in hepatic glycolysis-gluconeogenesis
metabolism and, in turn, in the control of glucose
homeostasis.
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